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Abstract
Objective: To identify regimen, individual, community and cultural factors that affect
adoption and adherence to weekly vitamin A supplementation in Ghana.
Design: Fifty semi-structured interviews were conducted with women who would be
eligible for vitamin A supplementation, 30 with husbands, and 13 with drug sellers,
birth attendants and health workers. Six focus group discussions were also conducted
with women. These interviews were followed by a 4-month capsule trial with 60
women. Data from a previously conducted communication channel survey of 332
women were also reviewed.
Setting: The study was conducted in Kintampo District in central Ghana.
Subjects: Participants for the semi-structured interviews and focus groups were
selected from four villages and the district capital, and women in the capsule trial
were selected at random from two villages.
Results: Knowledge of vitamins was low and taking ‘medicines’ for long periods and
when healthy is a new concept. In spite of this, long-term supplementation will be
accepted if motives are explained, specific questions answered and clear instructions
are given. Potential barriers included the idea of ‘doctor’ medicines as curative, false
expectations of the supplement, forgetting to take the supplement, losing the
supplement, travelling, lack of motivation, perceived side-effects, concerns that the
supplement is really family planning or will make delivery difficult, and concerns
about taking the supplement with other ‘doctor’ or herbal medicine, or when
pregnant or breast-feeding, or if childless.
Conclusion: Successful supplementation programmes require appropriately designed
information, education and communication strategies. Designing such strategies









There are approximately 529 000 maternal deaths world-
wide each year and more than 1 million children are left
motherless1–3. The main burden (99%) of maternal
mortality is in developing countries, and over half of the
deaths occur in Africa1. Vitamin A deficiency (VAD) is a
well-recognised nutritional problem in children in many
developing countries4 and it is well established that even
moderate deficiency increases a child’s risk of mortality
and severe infection5. It is also possible that VAD
contributes to maternal mortality. Evidence comes from
a field trial in Nepal, which reported a 44% reduction in
maternal mortality following weekly vitamin A or
b-carotene supplementation of women of reproductive
age6, and plausible biological pathways have been
identified7. If the Nepal finding is verified by trials in
Bangladesh and Ghana, vitamin A supplementation (VAS)
could become an important component of maternal health
programmes such as The Safe Motherhood Initiative,
particularly as current interventions are of questionable
effectiveness8 – 10. For example, data from the few
developing countries with vital registration indicate no
significant change in maternal mortality rates since the
start of The Safe Motherhood Initiative in 19879. VAS could
therefore be a potential breakthrough in reducing
maternal deaths.
Iron supplementation programmes have shown the
need for culturally acceptable information, education and
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communication (IEC) campaigns11–13, especially those
that focus on community perspectives, behaviour change
and increasing demand13–15, and have been criticised for
only recognising the need for IEC after evaluations show
they are ineffective15. Any Safe Motherhood VAS
programme must learn from the lessons of iron
supplementation and ensure that barriers and facilitators
to VAS are explored prior to the initiation of programmes
and that programmes include appropriate IEC strategies.
The present study aimed to identify regimen, individual,
community and cultural factors that affect the adoption
and maintenance of weekly VAS among women of
childbearing age in Ghana. This formative research was
done as a prelude to the implementation of a large-scale,
randomised, double-blind, placebo-controlled field trial
exploring the impact of vitamin A on maternal mortality In
Ghana. The estimated maternal mortality ratio for Ghana is
549 per 100 000 live births1.
Methods
The study was conducted in 2000 in Kintampo District,
which is situated in the centre of Ghana and lies within the
forest–savannah transitional ecological zone. Kintampo
District has an estimated population of 147 000 people; the
district is overwhelmingly rural and consequently farming
is the most important economic activity. Only the district
town and eight of the 149 villages have electricity, and few
can be reached by paved roads. There is one district
hospital, staffed by a clinical officer, and seven health
posts staffed by nurses.
Data were collected through semi-structured interviews
and focus group discussions (FGDs) followed by a pilot
capsule trial. All data collection instruments were pre-
tested and revised as needed. Informed consent was
sought from all respondents. The semi-structured inter-
views and FGDs were conducted in Kintampo town plus
four villages chosen purposively to reflect the district’s
range of health service accessibility, ethnicity, size of
village and location (Table 1).
Several respondent groups were included, namely the
potential target recipients of the VAS programme (women
of reproductive age), gatekeepers (husbands and village
leaders) and information providers (drug sellers, mid-
wives, traditional birth attendants and health workers). A
wide range of respondents were included in order to get a
broad picture of potential barriers and facilitators for VAS
adherence. The sample size for each respondent group
was determined using saturation sampling (i.e. respon-
dents were interviewed until no new information was
learnt).
Semi-structured interviews were conducted with 50
women aged 15–45 years and with 30 husbands. The
women were selected purposively to reflect differences in
age (#20, 21–35, 36–45 years), parity (0, 1–3, $4
children) and ethnicity (Northern tribe, Akan, Mo).
Thirteen in-depth interviews were conducted with drug
sellers, midwives, traditional birth attendants and health
workers, all of whom were identified from the semi-
structured interviews as being the most utilised in each
village. Fieldworkers conducted an average of two
interviews a day; they interviewed early in the morning
when most people were at home. Fieldworkers entered
compounds in different sections of the village and
interviewed respondents who met their age, parity and
ethnicity quota. During the interviews fieldworkers took
field notes, which they converted to detailed English
fairnotes on the day of the interview. Fairnotes were then
transcribed into Microsoft Wordw.
Six focus groups were conducted with six to 12 women
aged 15–45 years, stratified by age and ethnicity. Women
were selected by asking a community leader to select
talkative women who matched the specified age and
ethnicity requirements. FGDs were recorded and then
transcribed into English.
The information collected in the semi-structured inter-
views and the FGDs included perceptions of illness and
prevention, knowledge and experiences of vitamins and
vitamin A, adherence experiences, perceived barriers to
adherence and community solutions, desirable and undesir-
able capsule characteristics, acceptability of distribution
strategies, and exposure and experience with communi-
cation channels. The data were collected by five trained
fieldworkers in the local languages. The transcripts were
explored through multiple readings to ensure familiarity
with the data. Key analytic categories (issues, concepts
and themes) were then identified and the interviews and
FGDs were indexed into the categories and interpreted.
The semi-structured interviews and FGDs were col-
lected over 2 months; after they were completed, 60
women aged 15–45 years were randomly selected for the
capsule trial. Women were selected in two of the villages
Table 1 Community characteristics of the study villages
Kintampo town Village 1 Village 2 Village 3 Village 4 Village 5
Main ethnic group Mixed Dagarti Mo Gonja Akan Akan
Population 14 892 831 664 2042 2751 867
Electricity U £ £ £ £ £
Drinking water Wells Stream River Wells Stream River
Health post 1 – – – – 1
Hospital 1 – – – – –
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using the district’s demographic surveillance database.
Women who had responded to the semi-structured
interviews were excluded. The aim of the capsule trial
was to quantify the findings of the semi-structured
interviews and to uncover any missed barriers. Each
woman was visited at home and informed consent
obtained and any questions answered. They were
informed that we were planning to start a study exploring
whether vitamin A is good for women’s health and that we
would like to understand the problems women are likely
to have taking capsules. They were invited to help us
identify any problems by taking a capsule each week so
we could learn from their experiences. Each woman was
given a small bag of low-dose cod-liver oil capsules
(vitamin A capsules were unavailable), was instructed to
take a capsule on the same day every week and told that
the fieldworker would return in a month. Each month the
fieldworker returned, distributed more capsules and
administered a questionnaire about adherence, storage,
reminding strategies and respondents’ opinions of the
capsules. The trial lasted 4 months and the response rate
was 100%.
Data on availability and use of communication channels
in the district were available from a Health Seeking
Behaviour study conducted in the district in 199916. The
study included a health communication channel survey of
332 randomly selected women with children ,5 years of
age in eight villages. Some of the information was dated by
the time this adherence study was conducted, for example
a new popular local radio station began operation in 2000;




In the semi-structured interviews and FGDs, few
respondents, except the drug sellers and health workers,
had heard of the word ‘vitamin’ or the conventional local
language equivalent ‘medicine from food’. Of those who
had heard of vitamins, few could describe their function or
purpose, despite the widespread use of vitamins and
vitamin-based tonics as a treatment for common illnesses.
Druggists reported that vitamins and tonics make up a
large proportion of their business (B complex and
multivitamins being their best sellers) and were sold to
treat specific symptoms and illnesses. There was a high
level of knowledge in all respondent groups that ‘good-
quality’ foods such as beans, palm oil, meat and fish are
important for health, but methods of preventing adult
illness centred round avoiding behaviours linked to the
perceived cause of an illness, such as working in the sun.
Adopting a new behaviour
Taking ‘medicine’ such as VAS to prevent illness or
maintain health constitutes a new behaviour and some of
the women and the husbands said they could not see the
importance of taking supplements when healthy. Taking a
‘medicine’ for long periods of time also constitutes a new
behaviour as few women reported that they had ever
taken ‘medicine’, even prenatal supplements, for longer
than a month. Women reported that this new behaviour
would be acceptable if they saw other women taking the
supplement and were given detailed information before
starting to take the supplement. This desire for information
was in contrast to most women’s experiences, as they were
rarely told anything about the medicines or supplements
they had taken. The information women said they would
require (and in fact was frequently requested during
capsule trial informed consent) included an explanation of
why a healthy woman should take ‘medicine’ for a long
time, what the supplement does, what illness it cures,
whether it has side-effects, affects menstruation, has a
‘scent’ (bad taste) and costs anything, and what are the
motives of the people supplying it.
Maintaining the behaviour
Despite the acceptability of taking ‘medicine’ for long
periods and when not sick, a lack of motivation was
identified by women in the semi-structured interviews and
FGDs as a potential reason for non-adherence to VAS, as
women would get weary of taking ‘medicine’ after a long
period of time. The women also reported that forgetful-
ness would be an important reason for non-adherence; in
the capsule trial 19% of women reported missing at least
one capsule, the majority because they forgot due to being
busy or having an unusual schedule that day. When
women in the capsule trial missed one capsule they waited
until the next dosing day or stopped completely due to
concerns that the capsules must be taken exactly as
prescribed, i.e. consistently every week. Women in the
capsule trial used a variety of techniques to help them
remember to take the capsules, such as storing the capsule
with commonly used things (20% of women) and having
someone remind them (47%).
It became evident that women in the capsule trial
required information to be provided on an ongoing basis,
as information given during the consent procedure was
often forgotten or needed reinforcing if a woman’s
situation changed. For example, when women in the
capsule trial became pregnant, delivered a baby or
became ill they often stopped taking their capsules
completely as they needed reassurance that the capsules
were safe for their new condition. Other concerns about
taking supplements during pregnancy, reported by
women in the semi-structured interviews, FGDs and the
capsule trial, were whether taking ‘medicine’ during
pregnancy could make pregnancy-related nausea worse
or make the baby grow big in the womb and cause a
painful and difficult delivery. No concerns were raised
about taking ‘medicine’ when breast-feeding. Husbands
also reported concerns surrounding VAS and pregnancy,
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as they were worried that the supplement may affect
fertility or be a secret form of family planning. Husbands
also wanted to know why the supplement is only for
women.
Women in the semi-structured interviews and the FGDs
reported that they would stop taking VAS if they had side-
effects. They would also stop if they developed an illness
whilst taking the supplement, as they would assume that
the supplement either caused the illness or was ineffective
in preventing it, or they would think that the illness was a
side-effect of the supplement. They also reported that they
would not want to mix the supplement with ‘doctor’ or
herbal medicine. In fact, 16% of women in the capsule trial
reported that the capsule had caused a bad effect
(weakness, tiredness, sleepiness, dizziness) and 12%
reported being worried about taking the capsules. Capsule
sharing was not a problem, as ‘medicines’ were only
considered safe for those to whom they were prescribed.
No sharing was reported in the capsule trial, and women
and husbands in the semi-structured interviews reported
that they would not share medicine prescribed for
someone else.
Logistical barriers
Logistical barriers were identified by all of the respondent
groups in the semi-structured interviews and the focus
groups. Respondents felt that women who travelled may
forget to take their VAS with them or may run out of the
supplement whilst away. Several women in the capsule
trial missed doses because of travel.
Eighteen per cent of women in the capsule trial reported
losing some of their capsules: children’s curiosity and
inadequate packaging were often implicated in the loss.
However, only 12% of women reported storage as a
problem and 91% kept their capsules in good condition (as
observed by the fieldworker).
Distribution strategies
The husbands and the women in the semi-structured
interviews and the focus groups reported that the way VAS
was distributed would affect adherence. Women had a
strong preference for the supplement to be distributed
through monthly home visits by a non-community
member. The reasons given were that they felt that it
would be difficult to find time to go and collect the
capsules from a central place, that it would be difficult to
ensure they could be found at home on a weekly basis,
and that community members may be too busy to act as
distributors and would not be able to answer questions or
give advice. There was also a unanimous preference for
taking the capsule on the same day and at the same time,
as it was felt this would foster social support, reduce
forgetfulness and would also allow reminding activities to
be focused on a single day. Sunday morning emerged
as the preferred time and day since women are mostly at
home.
Capsule formulation
The size, shape, form and colour of the proposed
supplement (a small, transparent, honey-coloured gelatine
capsule) was acceptable to women in the semi-structured
interviews and FGDs because it was slippery, round, and
looked easy to swallow without chewing. However, most
women said they preferred taking red medicines as they
associated red with blood. The perception of blood as a
life force that is used up through work and illness, and
restored through diet, rest and certain medicines, is widely
held.
Communication channels
A variety of potential communication channels were
explored in the interviews with all the respondents. The
channels included community groups, churches and
mosques, schools, print materials (pamphlets, calendars,
posters, newspapers, billboards), mass media (radio,
television, videos, movies, loudspeaker vans, market
announcements), traditional channels (town criers, songs,
theatre) and health channels (maternal and child outreach
workers, antenatal care). Of these, the options respon-
dents felt would be most effective were town criers, radio,
posters, church, mosque and market announcements,
loudspeaker vans and a song.
The coverage of potential channels was explored using
the communication channel survey. Most villages had
radio reception but only 54% of households owned a radio
and only 36% of women reported listening to the radio in
the last month. Women listened at specific times of the day
and to specific programmes. The radio was considered a
very credible source of information and respondents felt
that radio messages would be passed around the
community. The fact that radio stations often broadcast
in only one local language was mentioned as a
disadvantage. Literacy was low with only 9% of women
able to read a sentence when tested, but respondents felt
they could find somebody who could read for them (57%
of women reported that somebody in their household
could read). Women liked the idea of having a calendar or
poster visible at home to help them remember to take the
capsule. Respondents felt that the poster should be mostly
pictorial with some writing to add credibility. Most women
felt that involving the churches and mosques was a good
idea, although they acknowledged that not all women
attend regularly.
Discussion
To date, intervention studies that have examined how to
enhance adherence in developing countries have focused
on the treatment of acute illness, and have had varying
success. They explored improving instructions, packa-
ging, dosing or treatment formulation17–25, but IEC
activities were absent. Evidence from programme evalu-
ations and observational studies of prenatal iron
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supplementation indicates that there are many barriers to
adherence that could be addressed through IEC11–15.
These include: a lack of knowledge of the supplement’s
purpose; low prioritisation of nutrient deficiencies;
misunderstanding instructions; side-effects; frustration at
having to take the supplement for a long time;
forgetfulness; migration; concerns that the supplement
causes excessive bleeding during birth; concerns around
taking the supplement when pregnant; and concerns that
the supplement will make the foetus big and delivery
difficult11,14,26,27. Most of these were also proposed by our
respondents as being likely barriers to adherence to VAS,
which suggests that prior to implementing any sup-
plementation programme for women it would be
important to explore these aspects through formative
research. Respondents’ concerns about taking the
supplement with other ‘doctor’ or herbal medicine, and
what to do if a dose is not taken at the prescribed time,
may also be relevant for adherence in other supplemen-
tation programmes. Formative research should also
address appropriate packaging to reduce capsule loss
and favourable formulation such as capsule colour and
size. For programmes that supplement non-pregnant
women, also relevant for adherence are respondents’
concerns that the supplement may affect menstruation, or
is really family planning in disguise.
The study also identified the importance of an
appropriate delivery system for the capsules, including
special arrangements for women when they travel away
from home. The experience of giving iron at antenatal care
visits suggests that centralised distribution can be
difficult11,26 and it is recognised that alternative delivery
systems may be needed13. Women in the present study
stated a preference for monthly home delivery of the
supplement, but this may not be feasible in large-scale
settings. Appropriate distribution systems provide an
accessible, constant supply of the supplement, and
development of suitable delivery systems needs to be a
key concern in any future vitamin A maternal mortality
programme. Intermittent supply has been a major barrier
to adherence in many supplementation pro-
grammes11,12,26.
The importance of formative research has been
emphasised by others15,28,29, and the present study
benefited from the multiple methods used. The semi-
structured interviews and the FGDs identified issues to be
explored in the capsule trial and also allowed issues that
could not be piloted, such as preferred communication
channels, to be explored in depth. The capsule trial
quantified the findings of the semi-structured interviews
and FGDs and thus provided information about the
relative importance of the barriers. The capsule trial also
uncovered barriers to adherence that the community
could not identify or predict, such as women stopping
taking the supplement if they missed a dose. Formative
research is, however, only the first step in developing an
IEC strategy. Programme planners need to ensure that
knowledge gained from formative research is translated
into appropriate actions and that communication experts
are utilised in designing the IEC strategy.
For example, the IEC strategy for the subsequent
vitamin A and maternal mortality trial in Ghana was
developed in five steps. First, information from the
formative research was presented at a workshop attended
by project staff, communications experts and staff from the
national vitamin A programme. The participants used the
information to identify the aims of the IEC strategy: to allay
fears, inform, motivate, remind, foster social support and
reduce logistical constraints. Second, the workshop
participants identified simple key messages (Table 2) to
help achieve the IEC aims. Third, the participants used the
communication information from the formative research
to develop a multi-pronged IEC strategy (Table 3) that
included appropriate communication channels for each
message. Fourth, a creative brief detailing each proposed
communication channel was developed and presented to
advertising companies, communication experts, musicians
and theatre directors. These experts developed a
communication plan and put in tenders for material
production. Fifth, the IEC materials were then developed
with the input of the community and extensively pre-
tested with the target populations.
The present paper describes research to uncover
potential barriers and facilitators to weekly VAS of
women. The information collected was used to design
an IEC strategy to enhance adherence to the supplement.
Although other studies have identified the need for IEC for
effective prenatal iron supplementation11–13, no rigorous
Table 2 Key messages for information, education and communi-
cation (IEC) activities, identified from the study findings
† Explain the use, importance and function of vitamins
† Stress the importance of being pro-active to maintain health,
and that women may need vitamins even if they feel healthy
† Distinguish vitamins from curative ‘doctor’ medicines and do
not give false expectations of what the supplement will do
† Emphasise that women will continue to get sick when they are
taking the supplement and the supplement does not cause
any illness, or interact adversely with any medicine
† Inform women of any potential side-effects before they start
taking the supplement
† Provide continuous information about the supplement,
especially when women become pregnant or sick, etc., or if
the information does not fit with local beliefs
† Reassure women that the supplement is safe to take whilst
pregnant, and as far as we know will not cause nausea or a
difficult delivery
† Include a motivational element in the IEC strategy
† Explicitly discuss the perception of the supplement as family
planning
† Provide clear instructions about what to do when women miss
a dose
† Emphasise that other women in the community are taking the
supplement
† Give advice about choosing a storage place that would also
serve as a reminder
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evaluations were located. The findings of the present
work, that formative research can identify potential
supplementation barriers and can be used to inform an
IEC strategy, must be followed by monitoring and
evaluation of IEC strategies to show whether they are
effective or not.
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